Navigation Links
Group B Strep: A Threat to Newborns That Doesn't Have to Be
Date:9/8/2007

Antibiotics during delivery protect against potentially deadly infection

FRIDAY, Sept. 7 (HealthDay News) -- One in four women carries the bacterium Group B streptococcus, the most common cause of life-threatening infections in newborns. Yet most women don't know it.

That same germ can wreak havoc on a newborn child, with infection during birth possibly leading to blindness, deafness, retardation, physical disability and, in the worst cases, death.

There's a simple test that can determine whether a pregnant woman carries GBS, and an effective antibiotic therapy for protecting her child during delivery. Yet, approximately one of every 100 to 200 babies whose mothers carry GBS will become infected and need treatment, according to the U.S. Centers for Disease Control and Prevention.

"It can kill and maim, and 90 percent of it is preventable," said Dr. James A. McGregor, visiting professor of clinical obstetrics and gynecology at the University of Southern California Keck School of Medicine in Los Angeles. "How often in life do you get the chance to prevent 90 percent of something awful?"

As a result, doctors are urging women to make sure they are tested for presence of the bacterium -- and that they make sure steps are taken during delivery to protect their baby.

With a swab of a woman's rectum and vagina, doctors can determine whether she carries GBS.

Both the U.S. Centers for Disease Control and Prevention and the Society of Obstetricians and Gynaecologists of Canada have guidelines that recommend that doctors screen every pregnant woman for GBS. The screening should take place between the 35th and 37th week of pregnancy. If a woman hasn't received a GBS screening by then, she should ask her doctor about it, according to the guidelines.

If a woman tests positive for GBS, she should be given intravenous antibiotics for at least four hours before she delivers, the guidelines say.

Doctors believe that babies who are infected take the bacterium into their bodies by ingesting GBS-containing amniotic or vaginal fluids during labor and delivery, according to the March of Dimes.

"We can't make a normal bacteria that's just living there go away by antibiotics," said Dr. Carol Baker, a professor of pediatrics, microbiology and immunology at the Baylor University College of Medicine, and head of the section for infectious diseases in the college's Department of Pediatrics. "But what we can do, if they are carrying the Group B strep, we give them antibiotic during labor.

"It fills the fluid around the baby, the amniotic fluid, with antibiotic," Baker said. "The baby is in an antibiotic bath, as it were." The antibiotic also floods the mother's blood and the birth canal.

"We can't make it [the germ] go completely away, but we can get the number really, really low -- enough so that the baby won't get a life-threatening infection," she said.

There's a one-in-100 chance that a GBS carrier's baby will become sick from infection with the bacterium. The risk rises to 4 percent under certain circumstances, including preterm delivery, prolonged rupture of the membranes, or fever during labor, according to the March of Dimes.

About 5 percent of babies infected with Group B strep die. Most who survive develop normally, but among those who develop meningitis as a result of GBS, up to 50 percent suffer lasting neurologic damage that can include cerebral palsy, sight and hearing loss, mental retardation, learning disabilities and seizures.

McGregor said that now that screening guidelines are in place, researchers want to eliminate the small number of infections that continue to occur. They are trying to figure out how to better improve the testing, making it quicker and more accurate. They're also looking at ways to make sure mothers get a sufficient dose of antibiotics, even if their labor appears to be a quick one, he said.

"Many hospitals used to have antibiotics on the ward that they could administer," McGregor said. "Now the request has to go to the pharmacy, and that can take an hour the mother might not have."

A potential vaccine that could be given to all women of childbearing years is another option.

"There's increasingly a clearly felt imperative to make a vaccine for Group B strep available for pregnant women," McGregor said.

There are a couple of candidate vaccines that have been identified, but research on them has ground to a halt, because no drug company is interested in pursuing them, he said. In effect, the Group B strep vaccine has become an "orphan" of medical science.

"We need to change our policies about 'orphan' vaccines and 'orphan' therapies," providing incentives and encouragement for research, McGregor said.

Finally, McGregor and Baker believe doctors need to better explain the GBS test at the time it is administered, so women with the bacterium understand that they need antibiotics and know to ask for them.

"If you say, 'I am group B strep positive, I need my antibiotics,' people will be responsive to you," Baker said. "We need to explain the test to the woman. Then she can really help advocate for the right thing being done in a timely fashion."

More information

To learn more, visit Group B Strep International.



SOURCES: Carol Baker, M.D., professor of pediatrics, microbiology and immunology at the Baylor University College of Medicine, and head of the section for infectious diseases in the college's Department of Pediatrics, Houston; James A. McGregor, M.D., visiting professor of clinical obstetrics and gynecology at the University of Southern California Keck School of Medicine in Los Angeles; U.S. Centers for Disease Control and Prevention, Atlanta; March of Dimes, White Plains, N.Y.


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. No link between blood groups and prostate cancer
2. Consumer group seeks Sibutramine ban
3. Suicide risk high in 12-17 Age Group
4. Religious groups overcome objections to cervical cancer vaccines
5. Wockhardt Group Plans Hospital In Delhi By End-2007
6. Group Suicides On The Rise In Japan
7. Yogic Moments: Age Old Yoga, Benefits All Age Groups
8. Group Jogging More Beneficial To Health Than Solo Jogging
9. Plastic Surgery Is Primetime among Ethnic Groups
10. Study Finds Online Support Groups Emotionally Benefit Women Suffering From
11. Specialist Services Can Help Ethnic Groups To Tackle Alcohol Misuse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Steve Helwig & Associates ... vital new community enrichment program, has teamed up with Citizens Opposed to Domestic Abuse ... from intimate abuse. To support all those victimized by the fear of violence in ...
(Date:2/8/2016)... , ... February 08, 2016 , ... Delta Dental of ... help combat pancreatic cancer. , Gary D. Radine, who recently retired as president and ... American Cancer Society’s 2015 CEO of the Year , helped lead the effort ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... While a significant number of women and men with eating disorders report a ... that best predicts the development of an eating disorder. , At the ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... than 50% lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort ... is time to make a change in public health,” states Carole Baggerly, Director ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... speaking on how healthcare companies can use newly released government data on populations ... a population and intervene and capture the value they create to succeed in ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... -- A research team led by St. Jude Children,s ... the abnormal breakage and rearrangement of chromosomes in white ... lymphoblastic leukemia (ALL). Such leukemias are cancers of white ... immature cells, called lymphoblasts. --> ... the type called "Ph-like ALL" will aid in designing ...
(Date:2/8/2016)... PALO ALTO, Calif. , Feb. 8, 2016 ... chemical manufacturing, and Kodiak Sciences Inc., a biopharmaceutical company ... retinal disease, announced today agreements for the clinical supply ... manufacture material at multiple sites, including Slough (UK), Visp ... --> Retinal diseases, such as age-related ...
(Date:2/8/2016)... 2016  The University of Michigan Health System in ... as part of the development of four new operating ... in the U.S. to start using new top-of-the-line neurosurgical ... chair of neurosurgery. --> Karin Muraszko ... The BrightMatter technology from Synaptive Medical – a ...
Breaking Medicine Technology: